L‐Asparaginase is a protein produced by Escherichia coli and exists in two types, A and B. Only type B shows a specific antitumor activity to acute lymphatic leukemia. A new recombinant E. coli BL21Gold (DE3) pET11a‐ansB was used to produce L‐asparaginase B in higher quantities. To enhance the purity and preserve the activity of L‐asparaginase B, crystallization is a promising process. Based on available patents, first experiments on L‐asparaginase B crystallization were performed. Recombinant L‐asparaginase B was successfully and reproducibly crystallized in two modifications. Up to now, it is not clear in which respect these two modifications of crystalline L‐asparaginase B differ. It is part of the current study to investigate the nature of protein crystals in detail. The investigations on lysozyme crystals are well in agreement with the literature.
No takes yet. Share an insight, caveat, or question.
Müller et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: